ALM Ortho raised $1 million in a funding round led by the Central Texas Angel Network (CTAN) and Keiretsu Forum. This capital will accelerate the development and commercialization of ALM Ortho’s implant solutions, designed to improve outcomes for patients undergoing complex limb restoration surgeries.
With a focus on addressing cases where traditional solutions fall short—such as osseointegration, limb lengthening, joint arthroplasty revisions, and trauma—ALM Ortho collaborates with surgeons to create tools that can transform the standard of care.
The $1 million raised in this Series A equity round will support the expansion of ALM Ortho’s product development pipeline and operational scaling.
“ALM Ortho’s technology promises to be truly life-changing for a large segment of amputees,” said Lance Adams, a member of CTAN’s Deal Team. “While we always desire positive returns on our investments, it is especially gratifying to be part of enhancing the lives of people in our communities by funding cutting edge technologies such as ALM Ortho.”
ALM Ortho raised $1 million in a funding round led by the Central Texas Angel Network (CTAN) and Keiretsu Forum. This capital will accelerate the development and commercialization of ALM Ortho’s implant solutions, designed to improve outcomes for patients undergoing complex limb restoration surgeries.
With a focus on addressing cases where...
ALM Ortho raised $1 million in a funding round led by the Central Texas Angel Network (CTAN) and Keiretsu Forum. This capital will accelerate the development and commercialization of ALM Ortho’s implant solutions, designed to improve outcomes for patients undergoing complex limb restoration surgeries.
With a focus on addressing cases where traditional solutions fall short—such as osseointegration, limb lengthening, joint arthroplasty revisions, and trauma—ALM Ortho collaborates with surgeons to create tools that can transform the standard of care.
The $1 million raised in this Series A equity round will support the expansion of ALM Ortho’s product development pipeline and operational scaling.
“ALM Ortho’s technology promises to be truly life-changing for a large segment of amputees,” said Lance Adams, a member of CTAN’s Deal Team. “While we always desire positive returns on our investments, it is especially gratifying to be part of enhancing the lives of people in our communities by funding cutting edge technologies such as ALM Ortho.”
Copy to clipboard 
